(Tiper Stock Exchange) – PharmaNutraa company listed on Euronext STAR Milan and active in the sector of mineral supplements and medical devices for muscles and joints, has stipulated three new international commercial agreements for distribution of the products of the SiderAL and Cetilar lines in the Republic of Indonesia, Kuwait and Mexico. Now the group can count on 47 distributors in 70 countries in Europe, Asia, Latin America and Africa.
“After the distribution agreements in Denmark and Albania relating to the products of the SiderAL line, it is a pleasure to be able to announce the closure of three new strategically very important collaborations, within the international expansion project of the PharmaNutra group,” said the managing director Charles Volpi.
“L’Indonesia represents a market with enormous potentialconsidering that we are talking about the fourth most populous nation in the world: it was a long process and now we are ready to reap the benefits of the excellent work carried out by our Foreign Business Development – he added – With regard to Kuwait and Mexico, even if deals with different numbers, we are talking about particularly relevant agreements from the point of view of commercial positioning”.